Digital AI and trusted data: The key to unlocking faster, more cost-... The artificial intelligence (AI) landscape is evolving at a rapid pace.
Digital Structuring the unstructured: Deterministic AI and white box... Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.
R&D Sponsored Patentability and predictability in AI-assisted drug discove... Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.
Digital An investor’s perspective on bio and tech Increasingly, the life sciences world is characterised by the collision of the worlds of technology and biology.
Digital AI drug discovery: Where we are and where we’re going The promise of AI in pharma is sprouting up across the business, from marketing to manufacturing to R&D.
R&D Talking techbio with NVIDIA: Accelerated computing, NLP, and... As Genentech and NVIDIA enter into a multi-year strategic AI research collaboration to accelerate drug discovery and development, web editor Nicole Raleigh revisits a recent discussion with
News Eisai debuts biliary tract cancer drug in Japan Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
